SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-024490
Filing Date
2021-05-06
Accepted
2021-05-06 06:55:49
Documents
61
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q reta-10q_20210331.htm   iXBRL 10-Q 1408551
2 EX-10.3 reta-ex103_270.htm EX-10.3 13047
3 EX-31.1 reta-ex311_9.htm EX-31.1 20421
4 EX-31.2 reta-ex312_6.htm EX-31.2 20166
5 EX-32.1 reta-ex321_7.htm EX-32.1 9900
6 EX-32.2 reta-ex322_8.htm EX-32.2 10011
7 GRAPHIC ggkge0wtsjca000001.jpg GRAPHIC 101396
  Complete submission text file 0001564590-21-024490.txt   4952978

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA reta-20210331.xsd EX-101.SCH 43569
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE reta-20210331_cal.xml EX-101.CAL 31747
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE reta-20210331_def.xml EX-101.DEF 136127
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE reta-20210331_lab.xml EX-101.LAB 320632
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE reta-20210331_pre.xml EX-101.PRE 232588
13 EXTRACTED XBRL INSTANCE DOCUMENT reta-10q_20210331_htm.xml XML 597454
Mailing Address 5320 LEGACY DRIVE PLANO TX 75024
Business Address 5320 LEGACY DRIVE PLANO TX 75024 972-865-2219
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37785 | Film No.: 21895680
SIC: 2834 Pharmaceutical Preparations